Loading…
Lobbying Spend
—
Filings
30
Firms Hired
1
Active Period
2019–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7389
Source: Senate LDA